Discovery of a new approach to inhibiting a highly treatment-refractory liver cancer

Reprogramming the rich connective tissue microenvironment of a liver cancer known as intrahepatic cholangiocarcinoma (ICC) inhibits its progression and resistance to standard chemotherapy in animal models, researchers from Massachusetts General Hospital (MGH) have found. This new treatment for a disease with extremely poor outcomes uses antibodies to block placental growth factor (PlGF), a member of […]

Continue Reading

Scientists develop method to more efficiently isolate and identify rare T cells

Scientists from the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have developed a technique that will enable researchers to more efficiently isolate and identify rare T cells that are capable of targeting viruses, cancer and other diseases. The approach could increase scientists’ understanding of how these critical immune […]

Continue Reading

How many tests after vasectomy? Guideline update leads to change in practice

A change in evidence-based guidelines for vasectomy may have led to a reduction in the number of follow-up tests to confirm the procedure was successful, reports a study in Urology Practice, an Official Journal of the American Urological Association (AUA). Originally published in 2012, and then updated in 2015, the AUA clinical guideline could significantly […]

Continue Reading